CYTOMX THERAPEUTICS INC's ticker is and the CUSIP is 23284F905. A total of 3 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -66.7% | 1,100 | -42.1% | 0.00% | – |
| Q2 2023 | $3 | -96.3% | 1,900 | -96.5% | 0.00% | – |
| Q1 2023 | $82 | +1071.4% | 54,600 | +1014.3% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 4,900 | +14.0% | 0.00% | – |
| Q3 2022 | $6,000 | -40.0% | 4,300 | -24.6% | 0.00% | – |
| Q2 2022 | $10,000 | -44.4% | 5,700 | -16.2% | 0.00% | – |
| Q1 2022 | $18,000 | -21.7% | 6,800 | +23.6% | 0.00% | – |
| Q4 2021 | $23,000 | +666.7% | 5,500 | +816.7% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -99.0% | 600 | +60.9% | 0.00% | -100.0% |
| Q1 2021 | $288,000 | – | 373 | +37200.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 1 | -90.0% | 0.00% | – |
| Q1 2018 | $6,000 | +500.0% | 10 | +400.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $151 | 0.00% |
| SIMPLEX TRADING, LLC | 54,600 | $82 | 0.00% |